Welireg 40 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FWW89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,968
Award facts
- Contract value 100% obligated
- $17,968.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $17,968.39 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Welireg 40 mg, an oral tyrosine kinase inhibitor used in cancer treatment. Issued on August 15, 2025, with a completion date of September 8, 2025, this firm fixed-price delivery order represents a competitive, non-set-aside procurement. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as the primary pharmaceutical supply vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As the incumbent prime vendor under the DLA's global pharmaceutical support program, the company maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic areas. The DLA Troop Support is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with anticipated multiple awards across separate regions, positioning this award within the context of ongoing federal pharmaceutical procurement strategy for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FWW89?
SPE2DB25FWW89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FWW89 worth?
The government has obligated $17,968 on SPE2DB25FWW89.
Is contract SPE2DB25FWW89 an order under another contract?
Yes. SPE2DB25FWW89 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWW89 competed?
The extent of competition for SPE2DB25FWW89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award